Faculty

John D. Day, MD, Chairperson
Director, Heart Rhythm Services
Intermountain Medical Center
Salt Lake City, UT

Douglas L. Packer, MD
Professor of Medicine
Director, Heart Rhythm Services, Cardiovascular Division
Mayo Clinic
Rochester, MN

Christopher R. Cole, MD
Colorado Cardiac Alliance Research Institute
Colorado Springs, CO

---

Target Audience:

Physicians, nurses, and technologists involved in the treatment of atrial fibrillation.

---

Learning Objectives:

Upon completion of this educational program, participants should be able to:
• - Discuss key elements needed to develop an atrial fibrillation (AF) program
• - Review successful initiatives used to increase patient referrals
• - Discuss recent updates to the guidelines of treating a patient with AF
• - Review processes, procedures, and equipment needed to set up a lab.

---

Accreditation:

MD/DO: This activity is sponsored by the No rth American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies .

Nurses: ANCC: NACCME is an approved provider of continuing nursing education by the Pennsylvania Sta te Nu rses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. This continuing nursing education activity was approved by the PA State Nurses Association for 1.5 contact hours (Provider Number 110-3-E-06). Provider approved by the California Board of Registered Nursing, Provider Number 13255, for 1.5 contact hours.

Technologists: Approved by The American Health c a re Radiology Administr ors for 1.5 Category A, AART continuing education credits.

---

Faculty Disclosure:

All those with control over the content of continuing education programs sponsored by NACCME are expected to disclose whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s). It is not assumed that these relationships will have an adverse impact on presentations; they are simply noted here to fully inform participants.

Dr. Day has disclosed that he has no significant financial relationship with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of his presentation.

Dr. Cole has disclosed that he has received grant/research support from St. Jude Medical, Medtronic, Guidant and Biotronik. He is a consultant to Medtronic and a member of the speakers’ bureau for St. Jude Medical, Medtronic and Guidant.

Dr. Packer has disclosed that he is a member of the speakers’ bureau for Bard, Biosense Webster, CryoCath, Hansen Medical, Medtronic, Philips, Sanofi-Aventis and St. Jude Medical. He is a member of the advisory board for GE Healthcare, Sanofi-Aventis, Siemens Medical and Symphony Medical. He is a consultant for Boston Scientific and Biosense Webster.

---

Commercial Supporter:

This activity is supported by an educational grant from St. Jude Medical.

---

This program is not part of the Heart Rhythm 2008 Official Scientific Sessions as planned by the Heart Rhythm Society Scientific Sessions Committee. This event is neither sponsored nor endorsed by the Heart Rhythm Society.

---

This activity is sponsored by the North American Center for Continuing Medical Education.

---